NFKB1 and chronic kidney disease: Upregulation of miR-181a can down-regulate the expression of CRY1 protein and promote the excretion of CRY1 by inhibiting NF-kB signal pathway, thus alleviating glomerulosclerosis and tubular epithelial injury in rats with chronic kidney disease.